Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Angiex, Inc.
Memorial Sloan Kettering Cancer Center
Agenus Inc.
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Valerio Therapeutics
Valerio Therapeutics
European Organisation for Research and Treatment of Cancer - EORTC